Pancreatic Cancer Research

ResearcherNortheastern UniversityNo recent work listed

Changyan Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1546-4011; OpenAlex author ID A5107224725. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. A comprehensive review of pancreatic cancer and its therapeutic challenges. Last author DOI 10.18632/aging.204310↗
  2. Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer. Co-author DOI 10.1002/jcp.28981↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shan Jiang · 1 shared paper, 2022 · strength 0.16
  2. Johan Bourghardt Fagman · 1 shared paper, 2022 · strength 0.16
  3. Hongmei Zhang · 1 shared paper, 2020 · strength 0.11
  4. Peipei Wang · 1 shared paper, 2020 · strength 0.11
  5. Tongbo Zhu · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.